Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease

Rituximab (RTX) is a monoclonal antibody directed against CD20 antigen indicated in an increasing number of immune-mediated diseases. While its efficacy in pemphigus vulgaris has been widely investigated, only a few data about its possible role in pemphigoid diseases have been reported in the litera...

Descripción completa

Detalles Bibliográficos
Autores principales: Baffa, Maria Efenesia, Corrà, Alberto, Maglie, Roberto, Mariotti, Elena Biancamaria, Montefusco, Francesca, Pipitò, Carlo, Senatore, Stefano, Quintarelli, Lavinia, Caproni, Marzia, Antiga, Emiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325091/
https://www.ncbi.nlm.nih.gov/pubmed/35887866
http://dx.doi.org/10.3390/jcm11144102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325091/
https://www.ncbi.nlm.nih.gov/pubmed/35887866
http://dx.doi.org/10.3390/jcm11144102

Ejemplares similares